Get the Stockscreener App
688.46
0.48%
-3.1619
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corporation stock is traded at $688.46, with a volume of 91,101.
It is down -0.48% in the last 24 hours and down -1.50% over the past month.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$691.62
Open:
$695.07
24h Volume:
91,101
Relative Volume:
0.12
Market Cap:
$85.63B
Revenue:
$377.60B
Net Income/Loss:
$3.35B
P/E Ratio:
27.45
EPS:
25.08
Net Cash Flow:
$5.67B
1W Performance:
+0.70%
1M Performance:
-1.50%
6M Performance:
+6.79%
1Y Performance:
+19.92%
1-Day Range:
$686.09
$695.07
1-Week Range:
$677.28
$696.47
52-Week Range:
$464.42
$737.89
Mckesson Corporation Stock (MCK) Company Profile
Name
Mckesson Corporation
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
688.40 | 85.41B | 377.60B | 3.35B | 5.67B | 25.08 |
|
COR
Cencora Inc
|
294.81 | 56.54B | 316.65B | 1.91B | 1.14B | 9.72 |
|
CAH
Cardinal Health Inc
|
150.28 | 35.53B | 222.58B | 1.57B | 1.85B | 6.45 |
|
HSIC
Henry Schein Inc
|
67.96 | 8.44B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.6611 | 939.13M | 2.22M | -5.63M | -1.68M | -0.24 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corporation Stock (MCK) Latest News
Quantitative breakdown of McKesson Corporation recent moveJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
Using data models to predict McKesson Corporation stock movement - Newser
Technical signs of recovery in McKesson CorporationWeekly Stock Analysis & AI Based Buy/Sell Signal Reports - Newser
Key resistance and support levels for McKesson CorporationTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
What high frequency data says about McKesson CorporationQuarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
McKesson Corporation stock momentum explained2025 Market Trends & Risk Adjusted Swing Trade Ideas - Newser
Is it time to cut losses on McKesson CorporationMarket Sentiment Report & Daily Momentum Trading Reports - Newser
Tools to assess McKesson Corporation’s risk profilePortfolio Gains Summary & Free Safe Entry Trade Signal Reports - Newser
Is McKesson Corporation stock overhyped or has real potential2025 Key Lessons & Daily Technical Forecast Reports - Newser
McKesson Corporation stock trend outlook and recovery pathInsider Buying & Long Hold Capital Preservation Plans - Newser
How high can McKesson Corporation stock go2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - Newser
McKesson Corporation stock retracement – recovery analysisEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
Is McKesson Corporation stock poised for growthPortfolio Performance Report & Stock Market Timing Techniques - Newser
Evaluating McKesson Corporation with trendline analysisMarket Trend Report & Weekly High Conviction Trade Ideas - Newser
Using R and stats models for McKesson Corporation forecastingQuarterly Market Summary & Stepwise Entry/Exit Trade Alerts - Newser
Combining machine learning predictions for McKesson CorporationEarnings Overview Summary & Weekly Top Stock Performers List - Newser
Can technical indicators confirm McKesson Corporation’s reversalBear Alert & Daily Entry Point Trade Alerts - Newser
Can trapped investors hope for a rebound in McKesson CorporationTrade Entry Summary & Precise Buy Zone Identification - Newser
Is McKesson Corporation stock reversal real or fake2025 Growth vs Value & Consistent Income Trade Recommendations - Newser
Dividend Information About McKesson: Everything You Need To Know Before Its Ex-Dividend Date of Sept 2, 2025 - AInvest
McKesson Stock Climbs 0.83 on $600M Volume Boosted by Tech Push and Analyst Buy Ratings - AInvest
What data driven models say about McKesson Corporation’s futureJuly 2025 PreEarnings & Precise Buy Zone Identification - Newser
Is it too late to sell McKesson CorporationJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser
Using flow based indicators on McKesson CorporationEarnings Overview Summary & Weekly Top Stock Performers List - Newser
What’s next for McKesson Corporation stock priceWeekly Trade Recap & AI Powered Market Entry Ideas - Newser
Ex-Dividend Reminder: Universal Health Services, McKesson and Safety Insurance Group - Nasdaq
Has McKesson Corporation found a price floorJuly 2025 Market Mood & Weekly Breakout Stock Alerts - Newser
Exit strategy if you’re trapped in McKesson Corporation2025 Market Outlook & Stepwise Entry and Exit Trade Signals - Newser
Mckesson Corporation Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):